MedPath

Prognostic Implications of Ductal Carcinoma in Situ Components in BRCA1/2-Positive Breast Cancer: a Retrospective Cohort Study

Not Applicable
Completed
Conditions
Neoplasms
Registration Number
KCT0009513
Lead Sponsor
Seoul National University Bundang Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
201
Inclusion Criteria

Breast cancer patients over 18 years old who had available results for BRCA mutations

Exclusion Criteria

Patients without BRCA mutation testing

Study & Design

Study Type
Observational Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath